MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Predicting risk of sarcopenia in people with Parkinson’s disease

A.P.C. Loureiro, B. Yamaguchi, I.L.P. Villegas, M.P. Ferreira, V.L. Israel (Curitiba, Brazil)

Meeting: 2016 International Congress

Abstract Number: 1752

Keywords: Aging, Rehabilitation

Session Information

Date: Thursday, June 23, 2016

Session Title: Other

Session Time: 12:00pm-1:30pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: This study aimed to evaluate the risk of sarcopenia in Parkinson’s disease (PD) community residents according a screening by using motor performance tests.

Background: Sarcopenia is known to affect elderly individuals by decreasing mobile function and increasing frailty and imbalance that can enhance the risk of falls in PD.

Methods: Individuals with PD in stages 1-4, according to the Hoehn and Yahr Scale, were assessed with the 10-Meter Walking Test, which provides gait velocity over a short distance, and with the handgrip strength test. For gait speed and handgrip strength, the cut-off values were 0.8 m/s and 20 kg for women and 30Kg for men, respectively.

Results: Forty-four participants with PD took part in the study (mean age 62,8±13 years; 26 males, 18 females; disease duration mean 6,69±5 years). The gait velocity obtained was of 1,18 ± 0,39 m/s and mean handgrip strength was of 28,73±9 Kg, being the mean of 22,84±5 kg for women and the mean of 31,96±9 kg for men. A moderate correlation was found between walking speed and grip strength. (r = 0.61, Spearman correlation coefficient).

Conclusions: There was no prevalence of sarcopenia in the studied group according to the screening criteria. However, associated with the aging process, motor and non-motor symptoms of the PD can cause problems to their functional performance and nutritional state, factors that may contribute to risk for sarcopenia.

To cite this abstract in AMA style:

A.P.C. Loureiro, B. Yamaguchi, I.L.P. Villegas, M.P. Ferreira, V.L. Israel. Predicting risk of sarcopenia in people with Parkinson’s disease [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/predicting-risk-of-sarcopenia-in-people-with-parkinsons-disease/. Accessed May 15, 2025.
  • Tweet
  • Email
  • Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/predicting-risk-of-sarcopenia-in-people-with-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Yerba Mate (Ilex paraguaiensis) protects dopaminergic neurons degeneration and improve their maturation in culture
  • #26133 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley